| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |